WC
LFCR icon

Walthausen & Co’s Lifecore Biomedical LFCR Stock Holding History

Walthausen & Co’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-387,467
Closed -$4.36M – 150
2021
Q2 		$4.36M Sell
387,467
-29,220
-7% -$337K 0.96% 20
2021
Q1 		$4.42M Sell
416,687
-9,880
-2% -$111K 0.93% 31
2020
Q4 		$4.63M Sell
426,567
-110,630
-21% -$1.14M 1.26% 12
2020
Q3 		$5.22M Buy
537,197
+46,950
+10% +$447K 1.08% 36
2020
Q2 		$3.9M Sell
490,247
-288,350
-37% -$2.98M 0.79% 60
2020
Q1 		$6.77M Sell
778,597
-399,703
-34% -$4.16M 1.45% 9
2019
Q4 		$13.3M Buy
1,178,300
+14,850
+1% +$158K 1.75% 5
2019
Q3 		$12.6M Hold
1,163,450
– – 1.75% 6
2019
Q2 		$10.9M Buy
1,163,450
+86,550
+8% +$874K 1.44% 13
2019
Q1 		$13.2M Buy
1,076,900
+348,485
+48% +$4.25M 1.72% 8
2018
Q4 		$8.62M Sell
728,415
-71,420
-9% -$981K 1.19% 25
2018
Q3 		$11.5M Buy
+799,835
New +$11.1M 1.11% 30
2018
Q1 		$10.2M Buy
777,745
+53,780
+7% +$707K 1% 46
2017
Q4 		$9.12M Sell
723,965
-108,750
-13% -$1.37M 0.86% 51
2017
Q3 		$10.8M Buy
832,715
+637,711
+327% +$8.41M 1.01% 47
2017
Q2 		$2.9M Buy
+195,004
New +$2.71M 0.28% 104

Other funds holding LFCR

WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Walthausen & Co's LFCR Position: Q3 2021 in Review

Walthausen & Co sold out of Lifecore Biomedical (LFCR) in Q3 2021, closing a stake of 387,467 shares — an estimated $4.36M sold.

Walthausen & Co first reported a position in LFCR in Q2 2017 and held it in 16 quarters. The position peaked at $13.3M in Q4 2019. 92 funds tracked by Wall St. Rank hold LFCR as of Q3 2021.

  • Walthausen & Co reported no remaining Lifecore Biomedical position as of Q3 2021 after selling out during the quarter.
  • Walthausen & Co sold 387,467 Lifecore Biomedical shares in Q3 2021, an estimated $4.36M.
  • Walthausen & Co first reported a position in Lifecore Biomedical in Q2 2017 and held it in 16 quarters.
  • Walthausen & Co's Lifecore Biomedical position peaked at $13.3M in Q4 2019.
  • 92 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q3 2021.

Based on Walthausen & Co's 13F filing for Q3 2021, filed 12 Nov 2021.